Dong-A St (170900)

Currency in KRW
43,150
+700(+1.65%)
Closed·
170900 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
42,30043,400
52 wk Range
38,95256,381
Key Statistics
Bid/Ask
43,150.00 / 43,250.00
Prev. Close
43,150
Open
43,250
Day's Range
42,300-43,400
52 wk Range
38,952-56,381
Volume
10.79K
Average Volume (3m)
25.58K
1-Year Change
-3.6011%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
170900 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
62,476
Upside
+44.79%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Dong-A St News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. For lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin inj./PFS for infertility and anovulation; Growtropin II inj./AQ /cartridge to treat growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Leucostim inj. for neutropenia in patients receiving myelosuppressive chemotherapy; Mainta inj. for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel inj. to treat breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone tab. for use in functional dyspepsia treatment; Stillen tab. to treat gastritis; Suganon tab./Sugamet XR tab. and Sugadapa tab./Sugatree XR tab for type 2 diabetes mellitus; Terizidone tab to treat active pulmonary and extra-pulmonary tuberculosis; and Zydena tab. for erectile dysfunction treatment. The company also provides licensed-in and licensed-out drugs; and medical devices, which cover high-technology medical devices, custom-made products, and sets of artificial cardiac circuits for use in open-heart surgery. Dong-A ST Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.

Employees
1679

Compare 170900 to Peers and Sector

Metrics to compare
170900
Peers
Sector
Relationship
P/E Ratio
−806.1x11.1x−0.5x
PEG Ratio
−8.10−0.200.00
Price/Book
0.6x0.8x2.6x
Price / LTM Sales
0.5x0.6x3.1x
Upside (Analyst Target)
43.5%40.5%58.4%
Fair Value Upside
Unlock17.6%9.3%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 62,476
(+44.79% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -39.78%
Dividend Yield
1.65%
Industry Median 0.86%
Annualized payout
700.00
Paid annually
5-Years Growth
-6.14%
Growth Streak

Earnings

Latest Release
Feb 09, 2026
EPS / Forecast
-- / 937.00
Revenue / Forecast
200.4B / 188.35B
EPS Revisions
Last 90 days

170900 Income Statement

FAQ

What Is the Dong-A St (170900) Stock Price Today?

The Dong-A St stock price today is 43,150 KRW.

What Stock Exchange Does Dong-A St Trade On?

Dong-A St is listed and trades on the Seoul Stock Exchange.

What Is the Stock Symbol for Dong-A St?

The stock symbol for Dong-A St is "170900."

Does Dong-A St Pay Dividends? What’s The Current Dividend Yield?

The Dong-A St dividend yield is 1.54%.

What Is the Dong-A St Market Cap?

As of today, Dong-A St market cap is 414.95B KRW.

What Is Dong-A St's Earnings Per Share (TTM)?

The Dong-A St EPS (TTM) is -40.

When Is the Next Dong-A St Earnings Date?

Dong-A St will release its next earnings report on May 18, 2026.

From a Technical Analysis Perspective, Is 170900 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Dong-A St Stock Split?

Dong-A St has split 4 times.

How Many Employees Does Dong-A St Have?

Dong-A St has 1679 employees.

What is the current trading status of Dong-A St (170900)?

As of Mar 24, 2026, Dong-A St (170900) is trading at a price of 43,150 KRW, with a previous close of 43,150 KRW. The stock has fluctuated within a day range of 42,300 KRW to 43,400 KRW, while its 52-week range spans from 38,952 KRW to 56,381 KRW.

What Is Dong-A St (170900) Price Target According to Analysts?

The average 12-month price target for Dong-A St is 62,476 KRW, with a high estimate of 66666.66667 KRW and a low estimate of 59047.61905 KRW. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +44.79% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.